Royal Bank of Canada’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Buy |
189,708
+184,383
| +3,463% | +$1.32M | ﹤0.01% | 3333 |
|
|
2025
Q1 | $32K | Buy |
5,325
+867
| +19% | +$5.21K | ﹤0.01% | 5359 |
|
|
2024
Q4 | $35K | Sell |
4,458
-4,801
| -52% | -$37.7K | ﹤0.01% | 5368 |
|
|
2024
Q3 | $100K | Buy |
9,259
+39
| +0.4% | +$421 | ﹤0.01% | 4892 |
|
|
2024
Q2 | $78K | Buy |
9,220
+7,359
| +395% | +$62.3K | ﹤0.01% | 5027 |
|
|
2024
Q1 | $13K | Sell |
1,861
-24,095
| -93% | -$168K | ﹤0.01% | 5646 |
|
|
2023
Q4 | $152K | Buy |
25,956
+14,197
| +121% | +$83.1K | ﹤0.01% | 4793 |
|
|
2023
Q3 | $115K | Buy |
11,759
+6,129
| +109% | +$59.9K | ﹤0.01% | 4811 |
|
|
2023
Q2 | $66K | Buy |
5,630
+2,027
| +56% | +$23.8K | ﹤0.01% | 5185 |
|
|
2023
Q1 | $39K | Sell |
3,603
-3,642
| -50% | -$39.4K | ﹤0.01% | 5367 |
|
|
2022
Q4 | $84K | Buy |
7,245
+6,182
| +582% | +$71.7K | ﹤0.01% | 5118 |
|
|
2022
Q3 | $16K | Buy |
1,063
+812
| +324% | +$12.2K | ﹤0.01% | 5736 |
|
|
2022
Q2 | $2K | Sell |
251
-2,032
| -89% | -$16.2K | ﹤0.01% | 6463 |
|
|
2022
Q1 | $17K | Sell |
2,283
-4,886
| -68% | -$36.4K | ﹤0.01% | 6194 |
|
|
2021
Q4 | $61K | Buy |
7,169
+3,342
| +87% | +$28.4K | ﹤0.01% | 5714 |
|
|
2021
Q3 | $32K | Buy |
3,827
+1,283
| +50% | +$10.7K | ﹤0.01% | 5898 |
|
|
2021
Q2 | $21K | Buy |
+2,544
| New | +$21K | ﹤0.01% | 6034 |
|
|
2021
Q1 | – | Sell |
-123
| Closed | -$1K | – | 6911 |
|
|
2020
Q4 | $1K | Buy |
+123
| New | +$1K | ﹤0.01% | 6371 |
|
|
2018
Q4 | – | Sell |
-42
| Closed | -$2K | – | 5841 |
|
|
2018
Q3 | $2K | Buy |
+42
| New | +$2K | ﹤0.01% | 5887 |
|